The expert panel voted on Thursday to recommend replacing the primary Covid-19 vaccine series with the BA.4/5 bivalent shot.

STAT's @helenbranswell and @matthewherper are tracking today's meeting of the Food and Drug Administration’s Vaccines and ...

Dr. Kristin Moffitt, an infectious disease specialist at Boston Children's Hospital talks about concerns about COVID vaccines ...

In a document posted ahead of an advisory group meeting on Jan 26, the US Food and Drug Administration (FDA) today spelled ...

The CDC and FDA announced ... the new Pfizer-BioNTech bivalent Covid-19 vaccine and strokes in people aged 65 and over, but said they were continuing to recommend the shots. The surveillance ...

The advisory panel mostly agreed with the FDA ... kids of immigrants COVID-19 vaccines have saved millions of lives and ...

A key advisory committee to the Food and Drug Administration met on Thursday to discuss the future of COVID-19 vaccination in ...

The FDA’s vaccine committee is set to consider a recommendation for an annual COVID-19 immunization plan, similar to the one ...

In a recent briefing document published by the United States Food and Drug Administration (US-FDA) ahead of an advisory ...

THURSDAY, Jan. 26, 2023 (HealthDay News) -- The U.S. Food and Drug Administration's vaccine advisory panel on Thursday voted ...

The FDA’s Vaccines and Related Biological Products Advisory Committee (VRBPAC) will meet Thursday to discuss how to simplify ...

The Food and Drug Administration's proposal was outlined in its briefing documents ahead of a meeting of its panel of ...